Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
McKesson
Merck
Harvard Business School
McKinsey

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR HYDRODIURIL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Hydrodiuril

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00797862 ↗ Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension Completed Novartis Phase 3 2008-11-01 This study will compare the safety and efficacy of initial combination treatment with aliskiren + amlodipine to sequential add-on treatment strategies with aliskiren or amlodipine in patients with hypertension.
NCT00896389 ↗ Salt Loading and Thiazide Intervention Study Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 4 2009-10-01 The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension.
NCT00896389 ↗ Salt Loading and Thiazide Intervention Study Completed University of Maryland Phase 4 2009-10-01 The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Hydrodiuril

Condition Name

Condition Name for Hydrodiuril
Intervention Trials
Hypertension 5
Hypertension, Grade 1 1
N of 1 Study Design 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Hydrodiuril
Intervention Trials
Hypertension 7
Proteinuria 1
Diabetes Mellitus, Type 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Hydrodiuril

Trials by Country

Trials by Country for Hydrodiuril
Location Trials
United States 3
Canada 1
Germany 1
South Africa 1
Venezuela 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Hydrodiuril
Location Trials
New Mexico 1
California 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Hydrodiuril

Clinical Trial Phase

Clinical Trial Phase for Hydrodiuril
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Hydrodiuril
Clinical Trial Phase Trials
Completed 5
Terminated 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Hydrodiuril

Sponsor Name

Sponsor Name for Hydrodiuril
Sponsor Trials
University of California, San Diego 2
University of Pittsburgh 1
University of New Mexico 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Hydrodiuril
Sponsor Trials
Other 15
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Colorcon
Harvard Business School
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.